Charlestown, Massachusetts Clinical Trials

A listing of Charlestown, Massachusetts clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 104 clinical trials
Study to Assess AFM24 in Advanced Solid Cancers

AFM24-101 is a first in human Phase 1/2a open-label, non-randomized, multi-center, multiple ascending dose escalation/expansion study evaluating AFM24 as monotherapy in patients with advanced solid malignancies whose disease has progressed after treatment with previous anticancer therapies. There will be two parts to this study: a dose escalation phase (1) and …

EGFR
colorectal cancer
non-small cell lung cancer
small cell lung cancer
kidney cancer
Dana Faber Cancer Institute
 (2.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +3 other locations
DS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST)

This study will assess the safety, efficacy, and pharmacokinetics of DS-6157a in participants with advanced gastrointestinal stromal tumors (GIST).

neutrophil count
gastrointestinal stromal tumor
platelet count
metastasis
minor surgery
Dana Farber Cancer Institute
 (2.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +1 other locations
A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19

The purpose of this study is to test the safety and tolerability of LY3819253 when it is given by injection into a vein to participants hospitalized with COVID-19. Blood tests will be done to check how much LY3819253 is in the bloodstream and how long the body takes to eliminate …

blood test
covid-19
Massachusetts General Hospital
 (0.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +10 other locations
Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19)

The objectives of this study are to evaluate the safety, tolerability and efficacy of AT-527 in older subjects (ages 45-80 years) with moderate COVID-19 and risk factors for poor outcomes (such as obesity (BMI>30), hypertension, diabetes or asthma). Eligible subjects will be randomized to blinded AT-527 (nucleotide analog) tablets or …

coronavirus infection
SARS
acute respiratory syndrome (sars)
asthma
hypertension
Atea Study Site
 (3.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +9 other locations
JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations

This is a Phase 1 study of JSI-1187 as monotherapy and in combination with dabrafenib for the treatment of advanced solid tumors with MAPK pathway mutations, including mutations that cause MAPK pathway hyperactivation.

neutrophil count
non-small cell lung cancer
small cell lung cancer
melanoma
metastatic melanoma
Massachusetts General Hospital Cancer Center
 (0.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +3 other locations
A Study of LY3819253 (LY-CoV555) in Participants With Mild to Moderate COVID-19 Illness

The purpose of this study is to measure how well LY3819253 works against the virus that causes COVID-19. LY3819253 will be given to participants with early symptoms of COVID-19, via an injection into a vein. Samples will be taken from the back of the nose to determine how much virus …

sickle cell anemia
malaise
throat
chronic disease
immunosuppressive agents
Massachusetts General Hospital
 (0.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +61 other locations
Lung Irradiation for COVID-19 Pneumonia

In this research study the investigators want to learn more about the potential benefit of radiation to the lung to improve the health of patients who are hospitalized with Coronavirus-19 (COVID-19) due to infection with a virus called SARS-CoV-2. This infection causes inflammation of the lung, which can make it …

coronavirus infection
lopinavir
oseltamivir
low dose radiation therapy
hydroxychloroquine
Brigham and Women's Hospital
 (3.0 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function

This exploratory, open-label clinical study aims to explore the physiologic effects of KB109, a novel glycan, on adult patients with COVID-19 illness on gut microbiota structure and function in the outpatient setting.

Massachusetts General Hospital
 (0.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Wellbeing Stress Reduction and Social Cognition

There are many ways to improve wellbeing. This study will compare two 8-week wellbeing training programs. In addition to looking at how well the programs reduce stress and enhance wellbeing, the investigators will also ask questions about how these programs influence cognition and decision making.

MGH
 (0.1 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Efficacy and Safety of Teicoplanin in CDAD

Primary Objective: Explore the efficacy of teicoplanin (100-200 mg administered orally twice a day for 7 to 14 days) in patients with Clostridium difficile infection-associated diarrhea and colitis Secondary Objective: Evaluate the safety of teicoplanin in patients with Clostridium difficile infection-associated diarrhea and colitis

Boston Medical Center
 (3.0 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +5 other locations